Success Story: A Cardiovascular Medicine Expert Gains NIW Approval in Over 1 Month under Premium Processing without RFE
Client’s Testimonial:
"I had a very positive experience. The team explained every step of the process clearly and was always willing to go over things multiple times whenever I had questions. At each stage, I was given detailed guidance on how to complete every form, including small details that are easy to miss. Because of this, I never had any confusion or doubts while filling out any part of the application. The team was also very responsive and promptly addressed all my questions and concerns. The entire process felt smooth and much easier because of your support. Everything was handled carefully and professionally, and I did not encounter any issues or errors. Overall, I am very satisfied with the service and would highly recommend your firm to others applying for a similar process.”
On May 2nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Resident Physician in the Field of Cardiovascular Medicine (Approval Notice).
General Field: Cardiovascular Medicine
Position at the Time of Case Filing: Resident Physician
Country of Origin: Pakistan
State of Residence at the Time of Filing: New York
Approval Notice Date: May 2nd, 2026
Processing Time: 1 month, 12 days (Premium Processing Requested)
Case Summary:
From a dedicated career in cardiovascular medicine research to a resident physician position in the field of cardiovascular medicine, and now an approved EB-2 NIW (National Interest Waiver) petition in just over 1 month without RFE, this is a remarkable milestone. With over 32,000 successful cases, our expert team is honored to have played a part in this physician-researcher's journey.
Client Background and Proposed Endeavor
Holding an M.B.B.S. and having cleared all three steps of the USMLE with full ECFMG certification, this physician-researcher brings deep specialized expertise in cardiovascular medicine, with a strong focus on early detection, risk assessment, and the management of heart disease. The proposed endeavor is to continue advancing research in this field, ultimately improving patient outcomes and contributing to more effective clinical decision-making and preventative strategies across the United States.
National Significance of the Research
We demonstrated that this work addresses one of the most pressing public health challenges facing the United States today. Cardiovascular disease continues to exact an enormous toll on both lives and the national economy, and the urgency for more effective early detection and risk prevention strategies has never been greater. By advancing data-driven approaches to cardiac diagnosis and risk assessment, this research aligns directly with federal priorities to reduce the national burden of cardiovascular disease, contributing to a healthier population, a more efficient healthcare system, and stronger long-term economic sustainability for the country.
Impressive Credentials and Achievements
To further strengthen the case, we highlighted exceptional credentials:
- Publications: An impressive portfolio of 18 peer-reviewed journal articles, 10 conference abstracts (1 first-authored), and 2 preprints.
- Citations: With 49 citations to the published body of work, research impact is well demonstrated.
- Peer Review Service: At least 3 peer reviews have been completed for authoritative journals.
Case Outcome
These pioneering contributions to cardiovascular medicine, spanning AI-driven cardiac imaging, cancer–heart failure risk factor analysis, and advanced diagnostic strategies for rare cardiac conditions, build a strong foundation for meaningful, lasting impact on U.S. public health and healthcare efficiency for years to come. We are honored to have supported this journey and extend our sincerest congratulations and best wishes for continued success in both medical practice and research pursuits.